Skip to content
Screener

Disc Medicine IRON Common Stock

Common Stock at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$292M0.0%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$1K0.0%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$76K+2.7%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$1.03M+2.1%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
500M+253,707%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$81K+3.8%

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.97B+45.5%
Enterprise value$2.92B+49.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: Disc Medicine’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 8:33 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-205192
Line itemMarch 31,2026December 31,2025
Commitments and contingencies (Note 14)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued or outstanding as of March 31, 2026 and December 31, 2025
Common stock, $0.0001 par value; 100,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 38,190,464 and 37,890,616 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively44
Additional paid-in capital1,262,6861,249,043
Accumulated other comprehensive (loss) income(571)965
Accumulated deficit(573,690)(510,186)
Total stockholders’ equity688,429739,826

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Disc Medicine's common stock?
Disc Medicine (IRON) reported common stock of $4K in Q1 2026.
How has Disc Medicine's common stock changed year-over-year?
Disc Medicine's common stock increased by 33.3% year-over-year, from $3K to $4K.
What is the long-term trend for Disc Medicine's common stock?
Over 5 years (2020 to 2025), Disc Medicine's common stock has grown at a 14.9% compound annual growth rate (CAGR), from $2K to $4K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Disc Medicine's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude